Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron vs Granisetron for CINV in Chinese Cancer Patients
NCT00666783Phase 2Completed
- Sponsor
- Xijing Hospital
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Xijing Hospital. Status: completed.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00666783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00666783.